We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The carnivores you can feed, when your site must be registered, authorised, or recognised, and the animal by-products you can use.
Form for approval to process animal by-products (ABPs) at your processing facility.
Check the tariff classification for vitamin gummies.
Check the tariff classification for flavour pods.
Regulations to reduce the risk posed by the production, importation and storage of ammonium nitrate.
Food and drink labelling and packaging regulations - what you must show, warnings, health and organic labels and packaging standards.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
Information for healthcare professionals on the diagnosis, prevention and treatment of hepatitis B.
Use IPAFFS to notify enforcement authorities about imports to Great Britain.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
A national point prevalence survey on healthcare associated infections (HCAIs), antimicrobial use (AMU) and antimicrobial stewardship (AMS) in England, 2023.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Marketing standards for poultry meat producers, manufacturers, retailers and distributors.
How to use a cost effectiveness analysis to evaluate your digital health product.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.